Page last updated: 2024-10-22

amiodarone and Precursor Cell Lymphoblastic Leukemia-Lymphoma

amiodarone has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briassoulis, G1
Stefanaki, K1
Peristeri, I1
Endoh, Y1
Hatzis, T1

Other Studies

1 other study available for amiodarone and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Is KL-6 a serum indicator of early pulmonary fibrosis in childhood cancer patients?
    Medical and pediatric oncology, 2003, Volume: 40, Issue:1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Biopsy; Bone Marrow Tr

2003